AstraZeneca COVID-19 vaccine and blood clots
The Medicines and Healthcare products Regulatory Agency (MHRA) has said the available evidence does not suggest that blood clots in veins (venous thromboembolism) are caused by the COVID-19 Vaccine AstraZeneca. This follows a detailed review of report cases as well as data from hospital admissions and GP records. This has been confirmed by the Government’s independent advisory group, the Commission on Human Medicines, whose expert scientists and clinicians have also reviewed the available data.
A further detailed review into five UK reports of a very rare and specific type of blood clot in the cerebral veins (sinus vein thrombosis) occurring together with lowered platelets (thrombocytopenia) is ongoing. This has been reported in less than 1 in a million people vaccinated so far in the UK and can also occur naturally – a causal association with the vaccine has not been established.
The MHRA’s advice remains that the benefits of being vaccinated continue to outweigh any risks and that the public should continue to get their vaccine when invited to do so.
The European Medicines Agency has concluded their review and stated that the benefits of vaccination still outweigh the risks despite a possible link to rare cerebral blood clots with low blood platelets. A review into whether the vaccine could be the cause of this rare type of cerebral blood clot alongside low blood platelets is ongoing and the EMA, working alongside the MHRA, will continue to investigate this.
Information for patients and the public
- Thrombotic events in veins are common in the general population and have not previously been associated with vaccination.
- From the millions of people already vaccinated with the AstraZeneca Vaccine, there is no evidence of an increased incidence of blood clots in veins (DVT) higher than that seen in the general population.
- There are no confirmed issues related to any batch of vaccine used across Europe, or the rest of the world. Additional testing has, and is, being conducted by AstraZeneca and independently by European health authorities and none of these re-tests have shown cause for concern.
- The MHRA is advising, as a precautionary measure, that anyone vaccinated who develops a headache that lasts for more than 4 days after vaccination or if they develop any bruising beyond the site of vaccination after a few days, should seek medical attention.
- Mild flu-like symptoms remain one of the most common side effects of any COVID-19 vaccine, including headache, chills and fever. These generally appear within a few hours and resolve within a day or two, and not everyone gets them.
- Covid-19 Overview
- Covid-19 Support (UPDATED)
- Covid-19 Test and Trace
- Covid-19 Vaccination Program (UPDATED)
- Covid-19 vaccination: why you are being asked to wait
- Covid 19: Book a Lateral Flow test (UPDATED)
- Covid 19: Surge Testing
- Instructions when attending Putneymead for an appointment in the isolation Room
Coronavirus (COVID-19) vaccine
- UPDATE: Digital COVID Pass
- NEW: Book or manage a Covid - 19 Vaccination
- NEW: Tell the NHS about coronavirus (COVID-19) vaccinations you've had abroad
- UPDATE: London COVID-19 Vaccine Clinical Reference Group 23.09.2021
- NHS APP (UPDATED)
- NEW: Residents in England who have taken part in COVID-19 vaccine clinical trials
- Covid 19: DISINFORMATION
- AstraZeneca COVID-19 vaccine
- Who can get the COVID-19 Vaccine
- Advice if you're of childbearing age, pregnant or breastfeeding
- How the COVID-19 vaccine is given?
- How safe is the COVID-19 vaccine?
- How effective is the COVID-19 vaccine?
- How you will be contacted for your coronavirus (COVID-19) vaccination
- What happens at your appointment?
- What to expect after your COVID-19 vaccination
- Can you go back to normal activities after having your vaccine?
- Can you catch COVID-19 from the vaccine?
- What to do next
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.